latest news releases from the newsroom
Evercel Audited Financials Complete
HINGHAM, Mass., Nov. 15, 2007 (PRIME NEWSWIRE) -- Evercel, Inc. (Pink Sheets:EVRC) today announced that it has received audited financial statements from its independent auditors for the years ended December 31, 2003, 2004 and 2005. Shareholders may obtain a copy by request from the company. Garry Prime, CEO, stated "We continue to work diligently to get our accounting up to date. While we can give no assurance, we expect to be current on an annual basis and be able to report timely results next year."
Generex Biotechnology Corp.
Noted Wall Street Analyst Highlights Generex Biotechnology in Report
WORCESTER, Mass., Nov. 15, 2007 (PRIME NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, announced today that Charles V. Payne and Wall Street Strategies, an independent stock market research company, have published a report on the Company. Mr. Payne is the Chief Analyst at Wall Street Strategies, and is a frequent guest on several well-respected finance-oriented radio and television programs and is widely recognized in the media as a leader in the analyst community. He is routinely sought after for his market opinions by several prestigious news organizations.